Understanding Colorectal Cancer Risk for Symptomatic Patients Understanding Colorectal Cancer Risk for Symptomatic Patients
The results of this study suggest that a fecal immunochemical test alone with a single cut-off is inadequate for optimizing colorectal cancer diagnosis.Alimentary Pharmacology & Therapeutics
Source: Medscape Radiology Headlines - Category: Radiology Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Drugs & Pharmacology | Gastroenterology | Radiology | Study